{"id":"76faf826-2be2-463e-b787-67a4ad8b2b4e","slug":"robert-palmisano","name":"Robert J. Palmisano","bioBrief":"Healthcare executive with over 40 years of experience leading global medical technology companies. Served as President and CEO of Wright Medical Group N.V. from 2011 until its acquisition by Stryker Corporation in 2020 for approximately $4.7 billion. Previously CEO of ev3 Inc. (acquired by Covidien for $2.6B in 2010), IntraLase Corp. (IPO 2004, acquired by Advanced Medical Optics 2007), MacroChem Corporation, and Summit Technology (acquired by Alcon 2000). Chairman and CEO of Priveterra Acquisition Corporation since 2020. Providence College alumnus (class of 1966).","priorExits":null,"nationality":"American","verificationPosture":"verified","aliases":[],"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1492658/000114036119009312/formdef14a.htm","title":"Wright Medical Group N.V. DEF 14A Proxy Statement","sourceName":"SEC EDGAR"},{"url":"https://aeonbiopharma.com/team/robert-palmisano/","title":"Robert Palmisano - Board Member","sourceName":"AEON Biopharma"},{"url":"https://news.providence.edu/robert-j-palmisano-66/","title":"Robert J. Palmisano '66 - Providence College News","sourceName":"Providence College"}],"reviewStatus":"reviewed","createdAt":"2026-07-30T03:07:18.393Z","updatedAt":"2026-07-30T06:09:28.464Z","educations":[],"companyRoles":[{"id":"45d2cc6d-eee6-4488-aea8-8d4094b9571f","personId":"76faf826-2be2-463e-b787-67a4ad8b2b4e","companyId":"a0b5ff2e-e9d7-4110-9548-08d0bdd5b274","role":"ceo","roleTitle":"President and CEO","startDate":null,"endDate":null,"currentRole":false,"roleBasis":"verified_secondary","createdAt":"2026-07-30T03:07:19.166Z","company":{"slug":"wright-medical-group","name":"Wright Medical Group"}}],"boardRoles":[],"investorRoles":[],"foundings":[]}